Results 241 to 250 of about 11,612,374 (304)

Transposon Vectors Enable Accelerated Development of Cellular Assay Platforms for the Identification and Characterization of Anti-Viral Small-Molecule Cell-Entry Inhibitors and Neutralizing Antibodies. [PDF]

Biomedicines
Pißarreck M, Katsoutas K, Kinder CL, Stitz J.   +3 more
europepmc   +1 more source

Advancing Chikungunya Prevention and Vaccination in Mexico: A Position Paper by the Immunization Committee of the Mexican Association of Pediatric Infectious Diseases. [PDF]

Vaccines (Basel)
Vázquez-Narváez JA, Avilés-Robles M, Espinosa-Sotero C, Martínez-Longoria CA, Moreno-Espinosa S, Reyes-Berlanga ML, Chacon-Cruz E.   +6 more
europepmc   +1 more source

Vector competence of temperate and tropical mosquito species for Babanki virus. [PDF]

PLoS Negl Trop Dis
Ban M, Geolier V, Perthame E, Ferquel E, Faye M, Diagne MM, Ndiaye EH, Fall G, Diallo M, Lavillette D, Choumet V.   +10 more
europepmc   +1 more source

Advances in the application of recombinant herpesvirus-vectored vaccines in animal disease control. [PDF]

Front Microbiol
Guo J, Mei C, Sun X, Lin Q, Bu W, Xie S, Jiang B.   +6 more
europepmc   +1 more source

Non-viral vectors for cancer therapy

Non-viral vectors for cancer therapy
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Non-viral vectors for the mediation of RNAi

Bioorganic Chemistry, 2012
Though the delivery of siRNA into cells, tissues or organs remains to be a big obstacle for its applications, recently siRNA therapeutics has developed rapidly and already there are clinical trials ongoing or planned. Some non-viral vectors have attracted much more attention and shown the great potential for combating the delivery obstacle.
Shubiao, Zhang, Yinan, Zhao, Defu, Zhi, Shufen, Zhang   +3 more
openaire   +2 more sources

Production of Non Viral DNA Vectors

Current Gene Therapy, 2010
After some decades of research, development and first clinical approaches to use DNA vectors in gene therapy, cell therapy and DNA vaccination, the requirements for the pharmaceutical manufacturing of gene vectors has improved significantly step by step.
Martin, Schleef, Markus, Blaesen, Marco, Schmeer, Ruth, Baier, Corinne, Marie, George, Dickson, Daniel, Scherman   +6 more
openaire   +2 more sources

Non-viral vectors for gene-based therapy

Nature Reviews Genetics, 2014
Gene-based therapy is the intentional modulation of gene expression in specific cells to treat pathological conditions. This modulation is accomplished by introducing exogenous nucleic acids such as DNA, mRNA, small interfering RNA (siRNA), microRNA (miRNA) or antisense oligonucleotides.
Hao, Yin, Rosemary L, Kanasty, Ahmed A, Eltoukhy, Arturo J, Vegas, J Robert, Dorkin, Daniel G, Anderson   +5 more
openaire   +2 more sources

Synthetic Peptides As Non-Viral DNA Vectors

Current Gene Therapy, 2006
The use of multiple peptide motifs to provide effective gene delivery holds great promise as an elegant, non-immunogenic approach to gene therapy. The molecular understanding of cell and viral biology provides a strong foundation on which to pursue this objective. Synthetic peptides containing multiple lysines and/or arginines (occasionally ornithines)
Fabre, J W, Collins, L
openaire   +3 more sources